Fariborz Kamal
Overview
Fariborz Kamal received an average of $3M in total compensation, including $479K in salary, at 4D Molecular Therapeutics between 2022 and 2023.
Source: SEC filings on April 10, 2024 and April 12, 2023.
Related executives
We found six more executives who work or worked at 4D Molecular Therapeutics.
David Kirn
4D Molecular Therapeutics
Chief Executive Officer
Robert Kim
4D Molecular Therapeutics
Chief Medical Officer
August Moretti
4D Molecular Therapeutics
Chief Financial Officer
August Moretti
4D Molecular Therapeutics
Chief Financial Officer
Theresa Janke
4D Molecular Therapeutics
Chief of Staff
Robert Fishman
4D Molecular Therapeutics